Skip to content
HowShorted

KALA BIO, Inc. short interest in 2024

In 2024, KALA BIO, Inc.'s disclosed short interest ran from 1.26% of shares outstanding on 12 Jan 2024 to 0.55% on 31 Dec 2024, a change of -0.71 percentage points. The year's high was 1.26% on 12 Jan 2024 and its low 0.18% on 15 Apr 2024, averaging 0.51% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.29 days on 15 Oct 2024. Full history: KALA BIO, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for KALA BIO, Inc. in 2024

2024 in figures

Start of year
1.26% (12 Jan 2024)
End of year
0.55% (31 Dec 2024)
Change
-0.71 pp
High
1.26% (12 Jan 2024)
Low
0.18% (15 Apr 2024)
Average
0.51%
Highest days to cover
3.29 (15 Oct 2024)
SEC filings marked
8

Every report in 2024

KALA BIO, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20241.26%1.00
31 Jan 20240.63%1.00
15 Feb 20240.45%1.00
29 Feb 20240.37%1.00
15 Mar 20240.45%1.00
28 Mar 20240.21%1.00
15 Apr 20240.18%1.0010-K filed, results (8-K)
30 Apr 20240.31%1.04
15 May 20240.21%1.0010-Q filed, results (8-K)
31 May 20240.27%1.00
14 Jun 20240.48%1.00
15 Aug 20240.68%1.3910-Q filed, results (8-K)
30 Aug 20240.49%3.15
13 Sep 20240.47%2.58
30 Sep 20240.65%1.85
15 Oct 20240.64%3.29
31 Oct 20240.81%1.27
15 Nov 20240.66%1.0010-Q filed, results (8-K)
29 Nov 20240.57%1.00
13 Dec 20240.47%1.00
31 Dec 20240.55%1.05

See also: KALA BIO, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.